Observational studyDigestive diseases and sciences2024

Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.

Teresa Valdés-Delgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.